These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24791833)

  • 1. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
    de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
    Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension.
    Goto I; Dohi K; Ogihara Y; Okamoto R; Yamada N; Mitani Y; Ito M
    Circ J; 2016; 80(4):989-97. PubMed ID: 26924211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
    Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
    Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
    Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
    PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary haemodynamics are correlated with intimal lesions in a rat model of severe PAH: attenuation of pulmonary vascular remodelling with ambrisentan.
    Takeuchi T; Sakao S; Kato F; Naito A; Jujo T; Yasuda T; Tanabe N; Tatsumi K
    Histol Histopathol; 2016 Dec; 31(12):1357-65. PubMed ID: 27048555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats.
    Silva MMCD; Alencar AKN; Silva JSD; Montagnoli TL; Silva GFD; Rocha BS; Montes GC; Mendez-Otero R; Pimentel-Coelho PM; Vasques JF; Trahez MM; Sudo RT; Zapata-Sudo G
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
    Yu M; Peng L; Liu P; Yang M; Zhou H; Ding Y; Wang J; Huang W; Tan Q; Wang Y; Xie W; Kong H; Wang H
    Drug Des Devel Ther; 2020; 14():1191-1202. PubMed ID: 32256050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Original rat model of high kinetic unilateral pulmonary hypertension surgically induced by combined surgery.
    Meng L; Liu X; Zheng Z; Li J; Meng J; Wei Y; Hu S
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1220-1226.e1. PubMed ID: 23395098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic overcirculation-induced pulmonary arterial hypertension in aorto-caval shunt.
    Rungatscher A; Linardi D; Milani E; Ucci G; Nicolato E; Merigo F; Salvetti B; Mazzucco A; Luciani GB; Faggian G
    Microvasc Res; 2014 Jul; 94():73-9. PubMed ID: 24862700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
    PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.
    Frump AL; Goss KN; Vayl A; Albrecht M; Fisher A; Tursunova R; Fierst J; Whitson J; Cucci AR; Brown MB; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L873-90. PubMed ID: 25713318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost reverses established fibrosis in experimental right ventricular failure.
    Gomez-Arroyo J; Sakagami M; Syed AA; Farkas L; Van Tassell B; Kraskauskas D; Mizuno S; Abbate A; Bogaard HJ; Byron PR; Voelkel NF
    Eur Respir J; 2015 Feb; 45(2):449-62. PubMed ID: 25261325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
    Happé CM; de Raaf MA; Rol N; Schalij I; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; de Man FS; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1088-97. PubMed ID: 27036867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.
    de Raaf MA; Kroeze Y; Middelman A; de Man FS; de Jong H; Vonk-Noordegraaf A; de Korte C; Voelkel NF; Homberg J; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1164-73. PubMed ID: 26386116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension.
    Karoor V; Strassheim D; Sullivan T; Verin A; Umapathy NS; Dempsey EC; Frank DN; Stenmark KR; Gerasimovskaya E
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on rat models of hypobaric hypoxia-induced pulmonary hypertension.
    Ma TT; Wang Y; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Yao XY; Gao ZM; Pan L
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3723-30. PubMed ID: 26502863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
    Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.